We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tissue Regenix Group Plc | LSE:TRX | London | Ordinary Share | GB00BNTXR104 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.70 | 2.84% | 61.50 | 61.00 | 62.00 | 61.50 | 61.50 | 61.50 | 118 | 08:00:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 24.48M | -2.7M | -0.0382 | -16.10 | 43.4M |
TIDMTRX
RNS Number : 5642N
Tissue Regenix Group PLC
09 August 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or Tissue Regenix Group plc the underlying issuer of existing shares to which voting rights are attached: (ii) --------------------------------------------------------------- ---------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): --------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights ---------------------------------------------------------------------------------------- --- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ---------------------------------------------------------------------------------------- --- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ---------------------------------------------------------------------------------------- --- An event changing the breakdown of voting rights ---------------------------------------------------------------------------------------- --- Other (please Share placing X specify): --------------------------------------------------------- ----------------------------- --- 3. Full name of person(s) John Andrew Walter Samuel subject to the notification obligation: (iii) ----------------------------------------------------------- -------------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) ----------------------------------------------------------- -------------------------------- 5. Date of the transaction 9 August 2017 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- -------------------------------- 6. Date on which issuer 9 August 2017 notified: ----------------------------------------------------------- -------------------------------- 7. Threshold(s) that is/are Below 3% crossed or reached: (vi, vii) ----------------------------------------------------------- -------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE -------------- -------------------------- -------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights -------------- ------------ ------------ ------------ --------------------- ------------------- Direct Direct Indirect Direct Indirect (xi) (xii) -------------- ------------ ------------ ------------ ------- ------------ -------- --------- Ordinary Below 0.5p 24,276,928 24,276,928 3% ------------ ------------ ------------ ------- ------------ -------- --------- GB00B5SGVL29 -------------- ------------ ------------ ------------ ------- ------------ -------- --------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. -------------- ------------ -------------------------- --------------------- ------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) -------------- ------------ ------------ ------------ --------------------- ------------------- Nominal Delta -------------- ------------ ------------ ------------ --------------------- -------- --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------ -------------------------------------------------------- Below 3% ------------------------------------------ -------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ------------------------------------------------------------------------------- Proxy Voting: ------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ---------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ---------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ---------------- 13. Additional information: ------------------------------------------------------------- ---------------- 14. Contact name: Caitlin Pearson ------------------------------------------------------------- ---------------- 15. Contact telephone number: 07920 272 441 ------------------------------------------------------------- ----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUKSORBNAWRAR
(END) Dow Jones Newswires
August 09, 2017 10:00 ET (14:00 GMT)
1 Year Tissue Regenix Chart |
1 Month Tissue Regenix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions